Skip to main content
. 2018 Jul 11;13(7):e0200452. doi: 10.1371/journal.pone.0200452

Fig 2. TGFβ1 reduces cell viability and increases cell invasion in TGFβ1 sensitive NSCLC cell lines.

Fig 2

(A) CellTiter-Glo luminescent assays showed that 2.5 ng/ml TGFβ1 treatment for two weeks significantly reduced A549, NCI-H358 and NCI-H1993 cell viability but had no effects on NCI-H1975, NCI-H1650 and HCC827 cell growth (compared to control without treatment, *** P<0.001). (B) Cell invasion assays revealed that 2.5 ng/ml TGFβ1 treatment for two weeks significantly increased the number of A549, NCI-H358 and NCI-H1993 cells which migrated through the chambers. NCI-H1975, NCI-H1650 and HCC827 cells did not exhibit the similar properties.